IL1B and Insulin resistance: We also found that IL-1β blockade can substantially reduce macrophage-stimulated release of the proinflammatory cytokines and lipid mobilization in human adipocytes, which could provide a mechanistic link between IL-1β and insulin resistance at local and also systemic levels.